Triemli Hospital, also known in German as Stadtspital Triemli or Triemlispital, is a major hospital in the Swiss city of Zürich. The hospital is located in the western suburbs of the city, in the Friesenberg quarter and the Wiedikon district.

There are 550 beds in City Hospital Triemli.

During the past decade, City Hospital Triemli conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 1 clinical trials were completed. i.e. 12.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "City Hospital Triemli" #1 sponsor was "Swiss Group for Clinical Cancer Research" with 33 trials, followed by "University Hospital, Basel, Switzerland" with 6 trials sponsored, "Triemli Hospital" with 5 trials sponsored, "AO Clinical Investigation and Publishing Documentation" with 3 trials sponsored and "Biosensors Europe SA" with 3 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "City Hospital Triemli" #1 collaborator was "Triemli Hospital" with 2 trials as a collaborator, "University of Bern" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Central European Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "City Hospital Triemli" are "Lymphoma" (7 trials), "Coronary Artery Disease" (6 trials), "Breast Cancer" (5 trials), "Lung Cancer" (5 trials) and "Colorectal Cancer" (4 trials). Many other conditions were trialed in "City Hospital Triemli" in a lesser frequency.

Most popular intervention types in "City Hospital Triemli" are "Drug" (40 trials), "Biological" (10 trials), "Device" (9 trials), "Radiation" (9 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "cisplatin" (5 trials), "radiation therapy" (5 trials), "cyclophosphamide" (3 trials), "docetaxel" (3 trials) and "doxorubicin hydrochloride" (3 trials). Other intervention names were less common.

The vast majority of trials in "City Hospital Triemli" are 55 trials for "All" genders, 7 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "City Hospital Triemli". undefined are not yet recruiting, 7 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 46 completed trials in City Hospital Triemli, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in City Hospital Triemli, 3 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 7 trials that are defined as “Not Applicable".